TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TYRA

Tyra Biosciences Inc

Healthcare · Biotechnology

21.30$ +1.2% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns Tyra Biosciences Inc (TYRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.4% of the shares are freely tradable; institutional investors hold 111.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 111.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 50.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 22.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 69Mio.

Largest Shareholders

Institutions

Institutions TYRA
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 17.74 12,198,625 +0.0 06/30/2026
FMR Inc 12.97 8,920,513 +15.1 06/30/2026
Jupiter Topco LLC 6.33 4,352,448 +0.0 06/30/2026
HHG PLC 5.66 3,890,589 +32.5 03/31/2026
Alta Partners Management Company, L.P. 5.56 3,823,425 +0.0 06/30/2026
Nextech Invest, Ltd. 5.17 3,553,585 -12.4 06/30/2026
TCG Crossover Management, LLC 4.73 3,248,980 +0.0 06/30/2026
BlackRock Inc 4.41 3,031,972 +36.7 06/30/2026
T. Rowe Price Associates, Inc. 4.05 2,782,567 +182.2 06/30/2026

Funds

Funds TYRA
Name Stake (%) Shares Change (%) Date
Fidelity OTC 4.82 3,316,798 +0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TYRA
Person Role Shares Value As of Type
Harris Todd President and CEO 1,438,495 30,639,944 $ Sep 15, 2026 direct
Fuhrman Alan Chief Financial Officer 37,115 790,550 $ Sep 15, 2026 direct
Rueb Yuliya Vice President, Finance (PAO) 11,258 239,795 $ Sep 15, 2026 direct
Verjee Rehan Director 972 20,701 $ Sep 9, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 15, 2026 Harris Todd President and CEO Other 864 9.13 7,887
Sep 15, 2026 Rueb Yuliya Vice President, Finance (PAO) Other 2,925 9.13 26,702
Sep 15, 2026 Fuhrman Alan Chief Financial Officer Other 951 9.13 8,682
Sep 9, 2026 Verjee Rehan Director Buy 972 20.58 20,002

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?